Celecoxib Impurity 22 | CAS 2247197-67-5 - Request Quote
Celecoxib Impurity 22
| SZ CAT No: | SZ-C005032 |
| CAS No | 2247197-67-5 |
| Mol.F. | C19H17F3N2O3S |
| Mol.Wt. | 410.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Celecoxib Impurity 22 is chemically Ethyl 4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonate. Celecoxib Impurity 22 is supplied with detailed characterization data compliant with regulatory guideline. Celecoxib Impurity 22 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Celecoxib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2247197-67-5
Purchase 2247197-67-5
Order 2247197-67-5
Enquire 2247197-67-5
price of 2247197-67-5
2247197-67-5 Supplier
2247197-67-5 Manufacturer
2247197-67-5 Exporter
buy high quality Celecoxib Impurity 22
Purchase Celecoxib Impurity 22
Celecoxib Impurity 22 suppliers
Celecoxib Impurity 22 manufacturers
Celecoxib Impurity 22 price
Order Celecoxib Impurity 22
Enquire Celecoxib Impurity 22
Celecoxib Impurity 22 cost
Celecoxib Impurity 22 Supplier
Celecoxib Impurity 22 Distributor
Celecoxib Impurity 22 for Method Validation
Celecoxib Reference Standard
Celecoxib Impurity 22 for ANDA Filing
Celecoxib Impurity 22 for Forced Degradation Studies
Celecoxib Impurity 22 Identification Standards
Celecoxib Impurity 22 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.